Xindong S. Liu

Xinqiao, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Publisher Correction: SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Journal: Nature cell biology
Published: January 19, 2026

Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure.

Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure.

Journal: Science advances
Published: October 17, 2025

Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways.

Cancer stem cells orchestrate immune evasion through extracellular vesicle-mediated non-canonical signaling pathways.

Journal: Cancer cell
Published: June 04, 2025

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Journal: Nature cell biology
Published: June 02, 2025

The FoxO4/DKK3 axis represses IFN-γ expression by Th1 cells and limits antimicrobial immunity.

The FoxO4/DKK3 axis represses IFN-γ expression by Th1 cells and limits antimicrobial immunity.

Journal: The Journal of clinical investigation
Published: March 17, 2025

DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.

DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps.

Journal: Cancer cell
Published: November 12, 2024

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts.

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts.

Journal: Cancer cell
Published: June 30, 2024

The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitis.

The PGAM5-NEK7 interaction is a therapeutic target for NLRP3 inflammasome activation in colitis.

Journal: Acta pharmaceutica Sinica. B
Published: February 04, 2024

SOSTDC1 downregulation in CD4+ T cells confers protection against obesity-induced insulin resistance.

SOSTDC1 downregulation in CD4+ T cells confers protection against obesity-induced insulin resistance.

Journal: Cell reports
Published: January 30, 2024

Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization.

Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization.

Journal: Cancer cell
Published: August 01, 2023

Hypoxia-inducible factor 2α promotes pathogenic polarization of stem-like Th2 cells via modulation of phospholipid metabolism.

Hypoxia-inducible factor 2α promotes pathogenic polarization of stem-like Th2 cells via modulation of phospholipid metabolism.

Journal: Immunity
Published: March 10, 2023

The effects of Sodium-glucose cotransporter 2 inhibitors on adipose tissue in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.

The effects of Sodium-glucose cotransporter 2 inhibitors on adipose tissue in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.

Journal: Frontiers in endocrinology
Published: December 03, 2022
Showing 1-12 of 41

Last Updated: 09/26/2026